台股 » 個股 » 智基 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

智基

(6294)
可現股當沖
  • 股價
    102.5
  • 漲跌
    ▼0.5
  • 漲幅
    -0.49%
  • 成交量
    55
  • 產業
    上櫃 文化創意指數
  • 106人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
智基 (6294)籌碼相關-第一金-路竹 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

第一金-路竹 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2024/05/160.1106.5000.00107.000.11500.03%
2024/05/140.2103.5000.00102.000.21440.14%
2024/05/0800.002118.50118.00-2119-1.67%
2024/04/155116.5000.00117.0051074.65%
2024/04/124117.0000.00118.0041043.83%
2024/04/112118.0000.00119.5021011.96%
2024/04/102127.001127.00127.001951.04%
2024/04/0800.0011123.50123.50-1173-14.98%
2024/03/121117.5000.00117.001382.57%
2024/03/080.3114.0000.00113.500.3340.86%
2024/03/076114.0000.00114.0063417.43%
2024/02/0100.003112.00112.00-331-9.42%
2024/01/241110.5000.00110.501303.29%
2024/01/225111.001111.00111.5042913.35%
2024/01/161112.5000.00112.501293.43%
2024/01/101111.0000.00111.001283.46%
2023/12/051113.5000.00114.001214.63%
2023/10/310.2115.0000.00115.000.2201.00%
2023/10/170.1116.5000.00117.000.1240.41%
2023/10/130.2117.0000.00117.000.2250.80%
2023/09/2500.001113.50114.00-126-3.78%
2023/09/210114.0000.00114.000260.09%
2023/09/200114.0000.00114.000260.10%
2023/09/183114.005113.50115.00-226-7.47%
2023/09/1300.002114.00114.00-226-7.51%
2023/09/1200.004114.00113.50-427-14.81%
2023/09/0800.001113.00113.50-127-3.61%
2023/08/011111.5000.00111.001333.03%
2023/07/311111.5000.00111.501333.01%
2023/07/251111.0000.00110.501313.23%
2023/07/201108.5000.00108.001293.38%
2023/06/1400.003107.50107.50-354-5.49%
2023/05/3100.002108.50108.00-255-3.59%
2023/05/251110.0000.00110.001561.77%
2023/05/035109.0000.00108.505529.48%
2023/04/241108.5000.00109.001531.88%
2023/04/142110.5000.00111.002503.98%
2023/03/311118.0000.00118.001352.80%
2023/03/2000.000111.50110.00027-0.04%
2023/03/141112.0000.00112.001323.08%
2023/01/300108.5000.00108.500390.03%
2022/01/2100.000.1125.50125.00-0.121-0.46%
2021/12/210124.0000.00123.500310.13%
2021/12/080125.5000.00125.500280.03%
2021/12/070.1125.5000.00125.000.1280.17%
2021/09/170144.0000.00144.500330.06%
2021/03/0500.000131.00131.00027-0.01%
2021/03/0400.000.2129.00129.00-0.226-0.75%
2020/11/300119.0000.00121.500310.00%
2020/11/270.2119.5000.00121.500.2310.64%
2020/08/3100.002114.50114.00-258-3.44%
2020/08/0500.001106.00106.00-161-1.63%
2020/07/2700.001105.50105.50-163-1.58%
2020/07/0100.001107.00107.50-162-1.60%
2020/06/291107.0000.00107.501621.61%
2020/06/242115.7500.00116.002593.34%
2020/06/221115.0000.00114.501541.82%
2020/06/0300.001109.50109.00-155-1.82%
2020/06/011109.0000.00109.001541.83%
2020/03/1700.000.690.9090.90-0.635-1.56%
2019/03/1800.001112.00111.50-126-3.79%
2019/02/261110.5000.00109.001244.10%
2018/11/0600.001107.50106.00-129-3.39%
2018/11/051106.5000.00106.001303.30%
2018/09/041109.0000.00109.501521.90%
慧智基因前列腺癌基因檢測套組 推行至國內千名患者Anue鉅亨-2021/09/14
疫情推升醫材需求強 雃博5月營收創同期高 慧智基因寫新猷Anue鉅亨-2021/06/10
智基 相關文章
智基 相關影音